Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05481281Phase 3Unknown
Phase 3, randomised trial comparing Group Dexmedetomidine with Group Ketamine (2 arms). Primary endpoint: Change in Shivering grade at 60 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05481281.